Clinical trial
Feasibility of Early Gabapentin as an Intervention for Neurorecovery
NCT05302999 is registered in ClinicalTrials.gov with MetroHealth Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Feasibility of Early Gabapentin as an Intervention for Neurorecovery
- Lead sponsor
- MetroHealth Medical Center
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- March 14, 2022
- Completion date
- March 31, 2026
- Enrollment
- 26 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.